Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

J Urol. 2017 Mar;197(3 Pt 1):603. doi: 10.1016/j.juro.2016.12.059. Epub 2016 Dec 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Renal Cell*
  • Humans
  • Indazoles
  • Kidney Neoplasms*
  • Pyrimidines
  • Sulfonamides
  • Sunitinib

Substances

  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib
  • Sunitinib